{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:22:07Z","timestamp":1775539327071,"version":"3.50.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1038\/nrc1187","type":"journal-article","created":{"date-parts":[[2003,9,16]],"date-time":"2003-09-16T16:36:58Z","timestamp":1063730218000},"page":"721-732","source":"Crossref","is-referenced-by-count":5472,"title":["Targeting HIF-1 for cancer therapy"],"prefix":"10.1038","volume":"3","author":[{"given":"Gregg L.","family":"Semenza","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"BFnrc1187_CR1","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1128\/MCB.12.12.5447","volume":"12","author":"GL Semenza","year":"1992","unstructured":"Semenza, G. L. & Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447\u20135454 (1992).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc1187_CR2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","volume":"270","author":"GL Wang","year":"1995","unstructured":"Wang, G. L. & Semenza, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230\u20131237 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR3","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang, G. L., Jiang, B. -H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510\u20135514 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2001","unstructured":"Harris, A. L. Hypoxia \u2014 a key regulatory factor in tumor growth. Nature Rev. Cancer 2, 38\u201346 (2001).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1187_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet, P. et al. Role of HIF-1\u03b1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485\u2013490 (1998).","journal-title":"Nature"},{"key":"BFnrc1187_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/gad.12.2.149","volume":"12","author":"NV Iyer","year":"1998","unstructured":"Iyer, N. V. et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1\u03b1. Genes Dev. 12, 149\u2013162 (1998).","journal-title":"Genes Dev."},{"key":"BFnrc1187_CR7","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"HE Ryan","year":"1998","unstructured":"Ryan, H. E., Lo, J. & Johnson, R. S. HIF-1\u03b1 is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005\u20133015 (1998).","journal-title":"EMBO J."},{"key":"BFnrc1187_CR8","first-page":"1138","volume":"63","author":"B Krishnamachary","year":"2003","unstructured":"Krishnamachary, B. et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138\u20131143 (2003).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR9","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1038\/sj.onc.1204012","volume":"19","author":"CC Wykoff","year":"2000","unstructured":"Wykoff, C. C. et al. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19, 6297\u20136305 (2000).","journal-title":"Oncogene"},{"key":"BFnrc1187_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","volume":"3","author":"S Pennacchietti","year":"2003","unstructured":"Pennacchietti, S. et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347\u2013361 (2003).","journal-title":"Cancer Cell"},{"key":"BFnrc1187_CR11","doi-asserted-by":"publisher","first-page":"14517","DOI":"10.1073\/pnas.96.25.14517","volume":"96","author":"J Yu","year":"1999","unstructured":"Yu, J. et al. Identification and classification of p53-regulated genes. Proc. Natl Acad. Sci. USA 96, 14517\u201314522 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR12","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","volume":"94","author":"M Ema","year":"1997","unstructured":"Ema, M. et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1\u03b1 regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl Acad. Sci. USA 94, 4273\u20134278 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0925-4773(97)00674-6","volume":"63","author":"I Flamme","year":"1997","unstructured":"Flamme, I. et al. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1\u03b1 and developmentally expressed in blood vessels. Mech. Dev. 63, 51\u201360 (1997).","journal-title":"Mech. Dev."},{"key":"BFnrc1187_CR14","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.1074\/jbc.272.13.8581","volume":"272","author":"JB Hogenesch","year":"1997","unstructured":"Hogenesch, J. B. et al. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J. Biol. Chem. 272, 8581\u20138593 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.11.1.72","volume":"11","author":"H Tian","year":"1997","unstructured":"Tian, H., McKnight, S. L. & Russell, D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72\u201382 (1997).","journal-title":"Genes Dev."},{"key":"BFnrc1187_CR16","doi-asserted-by":"publisher","first-page":"39192","DOI":"10.1074\/jbc.C100428200","volume":"276","author":"K Brusselmans","year":"2001","unstructured":"Brusselmans, K. et al. Hypoxia-inducible factor-2\u03b1 (HIF-2\u03b1) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J. Biol. Chem. 276, 39192\u201339196 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR17","doi-asserted-by":"publisher","first-page":"32405","DOI":"10.1074\/jbc.C200328200","volume":"277","author":"Y Makino","year":"2002","unstructured":"Makino, Y. et al. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of thehypoxia-inducible factor-3\u03b1 locus. J. Biol. Chem. 277, 32405\u201332408 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick, R. K. & McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337\u20131340 (2001).","journal-title":"Science"},{"key":"BFnrc1187_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"AC Epstein","year":"2001","unstructured":"Epstein, A. C. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43\u201354 (2001).","journal-title":"Cell"},{"key":"BFnrc1187_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan, M. et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464\u2013468 (2001).","journal-title":"Science"},{"key":"BFnrc1187_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola, P. et al. Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468\u2013472 (2001).","journal-title":"Science"},{"key":"BFnrc1187_CR22","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","volume":"20","author":"N Masson","year":"2001","unstructured":"Masson, N. et al. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20, 5197\u20135206 (2001).","journal-title":"EMBO J."},{"key":"BFnrc1187_CR23","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1073\/pnas.181341498","volume":"98","author":"F Yu","year":"2001","unstructured":"Yu, F., White, S. B., Zhao, Q. & Lee, F. S. HIF-1\u03b1 binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl Acad. Sci. USA 98, 9630\u20139635 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR24","doi-asserted-by":"publisher","first-page":"25733","DOI":"10.1074\/jbc.M002740200","volume":"275","author":"ME Cockman","year":"2000","unstructured":"Cockman, M. E. et al. Hypoxia inducible factor-\u03b1 binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733\u201325741 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR25","doi-asserted-by":"publisher","first-page":"10430","DOI":"10.1073\/pnas.190332597","volume":"97","author":"T Kamura","year":"2000","unstructured":"Kamura, T. et al. Activation of HIF1\u03b1 ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl Acad. Sci. USA 97, 10430\u201310435 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271\u2013275 (1999).","journal-title":"Nature"},{"key":"BFnrc1187_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh, M. et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the \u03b2-domain of the von Hippel-Lindau protein. Nature Cell Biol. 2, 423\u2013427 (2000).","journal-title":"Nature Cell Biol."},{"key":"BFnrc1187_CR28","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","volume":"19","author":"K Tanimoto","year":"2000","unstructured":"Tanimoto, K., Makino, Y., Pereira, T. & Poellinger, L. Mechanism of regulation of the hypoxia-inducible factor-1\u03b1 by the von Hippel-Lindau tumor protein. EMBO J. 19, 4298\u20134309 (2000).","journal-title":"EMBO J."},{"key":"BFnrc1187_CR29","doi-asserted-by":"publisher","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","volume":"271","author":"B-H Jiang","year":"1996","unstructured":"Jiang, B. -H., Semenza, G. L., Bauer, C. & Marti, H. H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271, C1172\u2013C1180 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnrc1187_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0092-8674(02)01085-1","volume":"111","author":"JW Jeong","year":"2002","unstructured":"Jeong, J. W. et al. Regulation and destabilization of HIF-1\u03b1 by ARD1-mediated acetylation. Cell 111, 709\u2013720 (2002).","journal-title":"Cell"},{"key":"BFnrc1187_CR31","doi-asserted-by":"publisher","first-page":"19253","DOI":"10.1074\/jbc.272.31.19253","volume":"272","author":"B-H Jiang","year":"1997","unstructured":"Jiang, B. -H. et al. Transactivation and inhibitory domains of hypoxia-inducible factor 1\u03b1: modulation of transcriptional activity by oxygen tension. J Biol. Chem. 272, 19253\u201319260 (1997).","journal-title":"J Biol. Chem."},{"key":"BFnrc1187_CR32","doi-asserted-by":"publisher","first-page":"11205","DOI":"10.1074\/jbc.272.17.11205","volume":"272","author":"CW Pugh","year":"1997","unstructured":"Pugh, C. W. et al. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the \u03b1 subunit. J Biol. Chem. 272, 11205\u201311214 (1997).","journal-title":"J Biol. Chem."},{"key":"BFnrc1187_CR33","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1101\/gad.924501","volume":"15","author":"PC Mahon","year":"2001","unstructured":"Mahon, P. C., Hirota, K. & Semenza, G. L. FIH-1: a novel protein that interacts with HIF-1\u03b1 and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675\u20132686 (2001).","journal-title":"Genes Dev."},{"key":"BFnrc1187_CR34","doi-asserted-by":"publisher","first-page":"26351","DOI":"10.1074\/jbc.C200273200","volume":"277","author":"KS Hewitson","year":"2002","unstructured":"Hewitson, K. S. et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351\u201326355 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR35","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.1068592","volume":"295","author":"D Lando","year":"2002","unstructured":"Lando, D. et al. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858\u2013861 (2002).","journal-title":"Science"},{"key":"BFnrc1187_CR36","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1101\/gad.991402","volume":"16","author":"D Lando","year":"2002","unstructured":"Lando, D. et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466\u20131471 (2002).","journal-title":"Genes Dev."},{"key":"BFnrc1187_CR37","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1073\/pnas.082121399","volume":"99","author":"SA Dames","year":"2002","unstructured":"Dames, S. A. et al. Structural basis for HIF-1\u03b1\/CBP recognition in the cellular hypoxic response. Proc. Natl Acad. Sci. USA 99, 5271\u20135276 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR38","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1073\/pnas.082117899","volume":"99","author":"SJ Freedman","year":"2002","unstructured":"Freedman, S. J. et al. Structural basis for recruitment of CBP\/p300 by hypoxia-inducible factor-1\u03b1. Proc. Natl Acad. Sci. USA 99, 5367\u20135372 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR39","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature00767","volume":"417","author":"WC Hon","year":"2002","unstructured":"Hon, W. C. et al. Structural basis for the recognition of hydroxyproline in HIF-1\u03b1 by pVHL. Nature 417, 975\u2013978 (2002).","journal-title":"Nature"},{"key":"BFnrc1187_CR40","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min, J. H. et al. Structure of an HIF-1\u03b1-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886\u20131889 (2002).","journal-title":"Science"},{"key":"BFnrc1187_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1096\/fasebj.11.5.9141507","volume":"11","author":"KA Brand","year":"1997","unstructured":"Brand, K. A. & Hermfisse, U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11, 388\u2013395 (1997).","journal-title":"FASEB J."},{"key":"BFnrc1187_CR42","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1128\/MCB.21.10.3436-3444.2001","volume":"21","author":"TN Seagroves","year":"2001","unstructured":"Seagroves, T. N. et al. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21, 3436\u20133444 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc1187_CR43","first-page":"5328","volume":"57","author":"BH Jiang","year":"1997","unstructured":"Jiang, B. H., Agani, F., Passaniti, A. & Semenza, G. L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 57, 5328\u20135335 (1997).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR44","doi-asserted-by":"publisher","first-page":"38205","DOI":"10.1074\/jbc.M203781200","volume":"277","author":"R Fukuda","year":"2002","unstructured":"Fukuda, R. et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205\u201338211 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR45","first-page":"2330","volume":"63","author":"R Fukuda","year":"2003","unstructured":"Fukuda, R., Kelly, B. & Semenza, G. L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 63, 2330\u20132334 (2003).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR46","first-page":"95","volume-title":"Oxygen Sensing: Responses and Adaptation to Hypoxia","author":"T Hellwig-Burgel","year":"2003","unstructured":"Hellwig-Burgel, T., Stiehl, D. P. & Jelkmann, W. in Oxygen Sensing: Responses and Adaptation to Hypoxia (eds Lahiri, S., Semenza, G. L. & Prabhakar, N. R.) 95\u2013108 (Marcel Dekker, Inc., New York, 2003)."},{"key":"BFnrc1187_CR47","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","volume":"21","author":"E Laughner","year":"2001","unstructured":"Laughner, E. et al. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995\u20134004 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc1187_CR48","first-page":"1541","volume":"60","author":"H Zhong","year":"2000","unstructured":"Zhong, H. et al. Modulation of HIF-1\u03b1 expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutic. Cancer Res. 60, 1541\u20131545 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.14.4.391","volume":"14","author":"W Zundel","year":"2000","unstructured":"Zundel, W. et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391\u2013396 (2000).","journal-title":"Genes Dev."},{"key":"BFnrc1187_CR50","doi-asserted-by":"publisher","first-page":"32631","DOI":"10.1074\/jbc.274.46.32631","volume":"274","author":"DE Richard","year":"1999","unstructured":"Richard, D. E. et al. p42\/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274, 32631\u201332637 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR51","first-page":"4873","volume":"60","author":"A Sodhi","year":"2000","unstructured":"Sodhi, A. et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1\u03b1. Cancer Res. 60, 4873\u20134880 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR52","doi-asserted-by":"publisher","first-page":"14013","DOI":"10.1074\/jbc.M209702200","volume":"278","author":"N Sang","year":"2003","unstructured":"Sang, N. et al. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J. Biol. Chem. 278, 14013\u201314019 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR53","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","volume":"22","author":"CC Hudson","year":"2002","unstructured":"Hudson, C. C. et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22, 7004\u20137014 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc1187_CR54","first-page":"5830","volume":"59","author":"H Zhong","year":"1999","unstructured":"Zhong, H. et al. Overexpression of hypoxia-inducible factor 1\u03b1 in common human cancers and their metastases. Cancer Res. 59, 5830\u20135835 (1999).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR55","first-page":"3915","volume":"59","author":"D Feldser","year":"1999","unstructured":"Feldser, D. et al. Reciprocal positive regulation of hypoxia-inducible factor 1\u03b1 and insulin-like growth factor 2. Cancer Res. 59, 3915\u20133918 (1999).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR56","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","volume":"157","author":"KL Talks","year":"2000","unstructured":"Talks, K. L. et al. The expression and distribution of the hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157, 411\u2013421 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1187_CR57","first-page":"2493","volume":"62","author":"NJ Beasley","year":"2002","unstructured":"Beasley, N. J. et al. Hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 62, 2493\u20132497 (2002).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR58","first-page":"1527","volume":"20","author":"M Volm","year":"2000","unstructured":"Volm, M. & Koomagi, R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res. 20, 1527\u20131533 (2000).","journal-title":"Anticancer Res."},{"key":"BFnrc1187_CR59","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1054\/bjoc.2001.2018","volume":"85","author":"A Giatromanolaki","year":"2001","unstructured":"Giatromanolaki, A. et al. Relation of hypoxia inducible factor 1\u03b1 and 2\u03b1 in operable non-small cell lung cancer to angiogenic\/molecular profile of tumours and survival. Br. J. Cancer 85, 881\u2013890 (2001).","journal-title":"Br. J. Cancer"},{"key":"BFnrc1187_CR60","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0360-3016(02)02848-1","volume":"53","author":"MI Koukourakis","year":"2002","unstructured":"Koukourakis, M. I. et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53, 1192\u20131202 (2002).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrc1187_CR61","first-page":"1661","volume":"7","author":"P Birner","year":"2001","unstructured":"Birner, P. et al. Expression of hypoxia-inducible factor 1\u03b1 in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 7, 1661\u20131668 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc1187_CR62","first-page":"1830","volume":"61","author":"MI Koukourakis","year":"2001","unstructured":"Koukourakis, M. I. et al. Hypoxia inducible factor (HIF-1\u03b1 and HIF-2\u03b1) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 61, 1830\u20131832 (2001).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR63","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","volume":"94","author":"PH Maxwell","year":"1997","unstructured":"Maxwell, P. H. et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94, 8104\u20138109 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR64","first-page":"4010","volume":"60","author":"HE Ryan","year":"2000","unstructured":"Ryan, H. E. et al. Hypoxia-inducible factor-1\u03b1 is a positive factor in solid tumor growth. Cancer Res. 60, 4010\u20134015 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR65","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/sj.onc.1206385","volume":"22","author":"A Unruh","year":"2003","unstructured":"Unruh, A. et al. The hypoxia-inducible factor-1\u03b1 is a negative factor for tumor therapy. Oncogene 22, 3213\u20133220 (2003).","journal-title":"Oncogene"},{"key":"BFnrc1187_CR66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","volume":"14","author":"R Ravi","year":"2000","unstructured":"Ravi, R. et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1\u03b1. Genes Dev. 14, 34\u201344 (2000).","journal-title":"Genes Dev."},{"key":"BFnrc1187_CR67","first-page":"6548","volume":"61","author":"N Akakura","year":"2001","unstructured":"Akakura, N. et al. Constitutive expression of hypoxia-inducible factor 1\u03b1 renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61, 6548\u20136554 (2001).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR68","doi-asserted-by":"publisher","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","volume":"271","author":"BH Jiang","year":"1996","unstructured":"Jiang, B. H. et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771\u201317778 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR69","doi-asserted-by":"crossref","unstructured":"Chen, J. et al. Dominant-negative hypoxia-inducible factor 1\u03b1 reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am. J. Pathol. 1283\u20131291 (2003).","DOI":"10.1016\/S0002-9440(10)63924-7"},{"key":"BFnrc1187_CR70","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/82146","volume":"6","author":"AL Kung","year":"2000","unstructured":"Kung, A. L. et al. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nature Med. 6, 1335\u20131340 (2000).","journal-title":"Nature Med."},{"key":"BFnrc1187_CR71","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","volume":"1","author":"K Kondo","year":"2002","unstructured":"Kondo, K. et al. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237\u2013246 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc1187_CR72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","volume":"1","author":"JK Maranchie","year":"2002","unstructured":"Maranchie, J. K. et al. The contribution of VHL substrate binding and HIF-1\u03b1 to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1, 247\u2013255 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc1187_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00240-4","volume":"3","author":"FA Mack","year":"2003","unstructured":"Mack, F. A. et al. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell 3, 75\u201388 (2003).","journal-title":"Cancer Cell"},{"key":"BFnrc1187_CR74","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/418823a","volume":"418","author":"R Bernards","year":"2002","unstructured":"Bernards, R. & Weinberg, R. A. Metastasis genes: a progression puzzle. Nature 418, 823 (2002).","journal-title":"Nature"},{"key":"BFnrc1187_CR75","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/32925","volume":"392","author":"WG An","year":"1998","unstructured":"An, W. G. et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1\u03b1. Nature 392, 405\u2013408 (1998).","journal-title":"Nature"},{"key":"BFnrc1187_CR76","doi-asserted-by":"publisher","first-page":"9082","DOI":"10.1073\/pnas.97.16.9082","volume":"97","author":"RK Bruick","year":"2000","unstructured":"Bruick, R. K. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl Acad. Sci. USA 97, 9082\u20139087 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1187_CR77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/379088a0","volume":"379","author":"TG Graeber","year":"1996","unstructured":"Graeber, T. G. et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88\u201391 (1996).","journal-title":"Nature"},{"key":"BFnrc1187_CR78","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","volume":"93","author":"R Bos","year":"2001","unstructured":"Bos, R. et al. Levels of hypoxia-inducible factor 1\u03b1 during breast carcinogenesis. J. Natl Cancer Inst. 93, 309\u2013314 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1187_CR79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev.med.54.101601.152418","volume":"54","author":"GL Semenza","year":"2003","unstructured":"Semenza, G. L. Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54, 17\u201328 (2003).","journal-title":"Annu. Rev. Med."},{"key":"BFnrc1187_CR80","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","volume":"93","author":"M Hockel","year":"2001","unstructured":"Hockel, M. & Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst. 93, 266\u2013276 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1187_CR81","first-page":"2911","volume":"61","author":"DM Aebersold","year":"2001","unstructured":"Aebersold, D. M. et al. Expression of hypoxia-inducible factor 1\u03b1: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61, 2911\u20132916 (2001).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR82","first-page":"4316","volume":"62","author":"A Rapisarda","year":"2002","unstructured":"Rapisarda, A. et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62, 4316\u20134324 (2002).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR83","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","volume":"95","author":"EJ Yeo","year":"2003","unstructured":"Yeo, E. J. et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl Cancer Inst. 95, 516\u2013525 (2003).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1187_CR84","doi-asserted-by":"publisher","first-page":"29936","DOI":"10.1074\/jbc.M204733200","volume":"277","author":"JS Isaacs","year":"2002","unstructured":"Isaacs, J. S. et al. Hsp90 regulates a von Hippel-Lindau-independent hypoxia-inducible factor-1\u03b1-degradative pathway. J. Biol. Chem. 277, 29936\u201329944 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR85","first-page":"2478","volume":"62","author":"NJ Mabjeesh","year":"2002","unstructured":"Mabjeesh, N. J. et al. Geldanamycin induces degradation of hypoxia-inducible factor 1\u03b1 protein via the proteosome pathway in prostate cancer cells. Cancer Res. 62, 2478\u20132482 (2002).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR86","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/jcp.10306","volume":"196","author":"D Zagzag","year":"2003","unstructured":"Zagzag, D. et al. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1\u03b1) in glioma cell invasion. J. Cell. Physiol. 196, 394\u2013402 (2003).","journal-title":"J. Cell. Physiol."},{"key":"BFnrc1187_CR87","first-page":"235","volume":"2","author":"SJ Welsh","year":"2003","unstructured":"Welsh, S. J. et al. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1\u03b1 and vascular endothelial growth factor formation. Mol. Cancer Ther. 2, 235\u2013243 (2003).","journal-title":"Mol. Cancer Ther."},{"key":"BFnrc1187_CR88","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","volume":"3","author":"NJ Mabjeesh","year":"2003","unstructured":"Mabjeesh, N. J. et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3, 363\u2013375 (2003).","journal-title":"Cancer Cell"},{"key":"BFnrc1187_CR89","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","volume":"1","author":"SJ Mandriota","year":"2002","unstructured":"Mandriota, S. J. et al. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1, 459\u2013468 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc1187_CR90","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","volume":"88","author":"D Zagzag","year":"2000","unstructured":"Zagzag, D. et al. Expression of hypoxia-inducible factor 1\u03b1 in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88, 2606\u20132618 (2000).","journal-title":"Cancer"},{"key":"BFnrc1187_CR91","first-page":"717","volume":"50","author":"JE Price","year":"1990","unstructured":"Price, J. E., Polyzos, A., Zhang, R. D. & Daniels, L. M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50, 717\u2013721 (1990).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR92","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/35052535","volume":"2","author":"EC Holland","year":"2001","unstructured":"Holland, E. C. Gliomagenesis: genetic alterations and mouse models. Nature Rev. Genet. 2, 120\u2013129 (2001).","journal-title":"Nature Rev. Genet."},{"key":"BFnrc1187_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0092-8674(02)00621-9","volume":"108","author":"T Van Dyke","year":"2002","unstructured":"Van Dyke, T. & Jacks, T. Cancer modeling in the modern era: progress and challenges. Cell 108, 135\u2013144 (2002).","journal-title":"Cell"},{"issue":"Suppl.","key":"BFnrc1187_CR94","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jcb.10443","volume":"39","author":"MG Pomper","year":"2002","unstructured":"Pomper, M. G. Can small animal imaging accelerate drug development? J. Cell. Biochem. 39 (Suppl.), 211\u2013220 (2002).","journal-title":"J. Cell. Biochem."},{"key":"BFnrc1187_CR95","first-page":"2723","volume":"63","author":"D Artemov","year":"2003","unstructured":"Artemov, D., Mori, N., Ravi, R. & Bhujwalla, Z. M. Magnetic resonance molecular imaging of the her-2\/neu receptor. Cancer Res. 63, 2723\u20132727 (2003).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR96","first-page":"355","volume":"9","author":"ZM Bhujwalla","year":"2003","unstructured":"Bhujwalla, Z. M. et al. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin. Cancer Res. 9, 355\u2013362 (2003).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc1187_CR97","first-page":"500","volume":"43","author":"DA Mankoff","year":"2002","unstructured":"Mankoff, D. A. et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J. Nucl. Med. 43, 500\u2013509 (2002).","journal-title":"J. Nucl. Med."},{"key":"BFnrc1187_CR98","doi-asserted-by":"publisher","first-page":"50081","DOI":"10.1074\/jbc.M201095200","volume":"277","author":"XH Liu","year":"2002","unstructured":"Liu, X. H. et al. Prostaglandin E2 induces hypoxia-inducible factor-1\u03b1 stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. 277, 50081\u201350086 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR99","doi-asserted-by":"publisher","first-page":"28421","DOI":"10.1074\/jbc.M102847200","volume":"276","author":"K Fatyol","year":"2001","unstructured":"Fatyol, K. & Szalay, A. A. The p14ARF tumor suppressor protein facilitates nucleolar sequestration of HIF-1\u03b1 and inhibits HIF-1 mediated transcription. J. Biol. Chem. 276, 28421\u201328429 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1187_CR100","doi-asserted-by":"crossref","unstructured":"Iervolino, A. et al. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB J. 16, 1453\u20131455.","DOI":"10.1096\/fj.02-0122fje"},{"key":"BFnrc1187_CR101","first-page":"4693","volume":"60","author":"P Birner","year":"2000","unstructured":"Birner, P. et al. Overexpression of hypoxia-inducible factor 1\u03b1 is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60, 4693\u20134696 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc1187_CR102","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0360-3016(02)04579-0","volume":"56","author":"P Burri","year":"2003","unstructured":"Burri, P. et al. Significant correlation of hypoxia-inducible factor-1\u03b1 with treatment outcome in cervical cancer treated with radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 56, 494\u2013501 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrc1187_CR103","first-page":"1831","volume":"8","author":"M Schindl","year":"2002","unstructured":"Schindl, M. et al. Overexpression of hypoxia-inducible factor 1\u03b1 is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin. Cancer Res. 8, 1831\u20131837 (2002).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc1187_CR104","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/cncr.11246","volume":"97","author":"R Bos","year":"2003","unstructured":"Bos, R. et al. Levels of hypoxia-inducible factor-1\u03b1 independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97, 1573\u20131581 (2003).","journal-title":"Cancer"},{"key":"BFnrc1187_CR105","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F","volume":"92","author":"P Birner","year":"2001","unstructured":"Birner, P. et al. Expression of hypoxia-inducible factor-1\u03b1 in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 92, 165\u2013171 (2001).","journal-title":"Cancer"},{"key":"BFnrc1187_CR106","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cncr.10774","volume":"95","author":"E Sivridis","year":"2002","unstructured":"Sivridis, E. et al. Association of hypoxia-inducible factors 1\u03b1 and 2\u03b1 with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 95, 1055\u20131063 (2002).","journal-title":"Cancer"},{"key":"BFnrc1187_CR107","first-page":"797","volume":"10","author":"R Takahashi","year":"2003","unstructured":"Takahashi, R. et al. Hypoxia-inducible factor-1\u03b1 expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol. Rep. 10, 797\u2013802 (2003).","journal-title":"Oncol. Rep."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc1187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T19:12:05Z","timestamp":1704913925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc1187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":107,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["BFnrc1187"],"URL":"https:\/\/doi.org\/10.1038\/nrc1187","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}